{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:58:16Z","timestamp":1769547496616,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10067-023-06678-6","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T16:23:58Z","timestamp":1688574238000},"page":"3143-3152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study"],"prefix":"10.1007","volume":"42","author":[{"given":"Mahsa","family":"Mashayekhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirreza","family":"Khalaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6967","authenticated-orcid":false,"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"issue":"7","key":"6678_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrrheum.2011.7","volume":"7","author":"JM Hazes","year":"2011","unstructured":"Hazes JM, Luime JJ (2011) The epidemiology of early inflammatory arthritis. Nat Rev Rheumatol 7(7):381\u2013390. https:\/\/doi.org\/10.1038\/nrrheum.2011.7","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"6678_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00296-005-0027-x","volume":"26","author":"A Stockman","year":"2006","unstructured":"Stockman A, Tait BD, Wolfe R, Brand CA, Rowley MJ, Varney MD et al (2006) Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study. Rheumatol Int 26(6):500\u2013509. https:\/\/doi.org\/10.1007\/s00296-005-0027-x","journal-title":"Rheumatol Int"},{"key":"6678_CR3","doi-asserted-by":"publisher","first-page":"668898","DOI":"10.3389\/fmed.2021.668898","volume":"8","author":"M Novella-Navarro","year":"2021","unstructured":"Novella-Navarro M, Plasencia-Rodr\u00edguez C, Nu\u00f1o L, Balsa A (2021) Risk factors for developing rheumatoid arthritis in patients with undifferentiated arthritis and inflammatory arthralgia. Front Med (Lausanne). 8:668898. https:\/\/doi.org\/10.3389\/fmed.2021.668898","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"6678_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2005.038471","volume":"65","author":"J van Aken","year":"2006","unstructured":"van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TWJ (2006) Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 65(1):20\u201325. https:\/\/doi.org\/10.1136\/ard.2005.038471","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6678_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VPK Nell","year":"2004","unstructured":"Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43(7):906\u2013914. https:\/\/doi.org\/10.1093\/rheumatology\/keh199","journal-title":"Rheumatology (Oxford)"},{"issue":"5 Suppl 61","key":"6678_CR6","first-page":"S117","volume":"28","author":"K Visser","year":"2010","unstructured":"Visser K, Allaart CF, Huizinga TWJ (2010) Use of methotrexate in undifferentiated arthritis. Clin Exp Rheumatol 28(5 Suppl 61):S117\u2013S121","journal-title":"Clin Exp Rheumatol"},{"issue":"214","key":"6678_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.31729\/jnma.3893","volume":"56","author":"B Vaidya","year":"2018","unstructured":"Vaidya B, Baral R, Nakarmi S (2018) Early undifferentiated arthritis: a developing country perspective from Nepal. JNMA J Nepal Med Assoc 56(214):983\u2013990. https:\/\/doi.org\/10.31729\/jnma.3893","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"8","key":"6678_CR8","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1093\/rheumatology\/keab880","volume":"61","author":"M Verstappen","year":"2022","unstructured":"Verstappen M, Matthijssen XME, van der Helm-van Mil AHM (2022) Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies-results from a 25 year longitudinal inception cohort. Rheumatology (Oxford) 61(8):3212\u20133222. https:\/\/doi.org\/10.1093\/rheumatology\/keab880","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"6678_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/annrheumdis-2021-221821","volume":"81","author":"NK den Hollander","year":"2022","unstructured":"den Hollander NK, Verstappen M, Huizinga TWJ, van der Helm-van MA (2022) Management of contemporary early undifferentiated arthritis: data on EULAR\u2019s recommendation on the risk of persistent disease. Ann Rheum Dis 81(5):740\u2013741. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221821","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6678_CR10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2012-203165","volume":"72","author":"KV Wevers-de Boer","year":"2013","unstructured":"Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF (2013) Drug therapy in undifferentiated arthritis: a systematic literature review. Ann Rheum Dis 72(9):1436\u20131444. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203165","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6678_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2016-210602","volume":"76","author":"B Combe","year":"2017","unstructured":"Combe B, Landewe R, Daien CI, Hua C, Aletaha D, \u00c1lvaro-Gracia JM et al (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 76(6):948\u2013959. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210602","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"6678_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.autrev.2011.10.019","volume":"11","author":"I Olivieri","year":"2012","unstructured":"Olivieri I, Sarzi-Puttini P, Bugatti S, Atzeni F, d\u2019Angelo S, Caporalil R (2012) Early treatment in early undifferentiated arthritis. Autoimmun Rev 11(8):589\u2013592. https:\/\/doi.org\/10.1016\/j.autrev.2011.10.019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"6678_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/kep392","volume":"49","author":"K Raza","year":"2010","unstructured":"Raza K (2010) The Michael Mason prize: early rheumatoid arthritis-the window narrows. Rheumatology (Oxford) 49(3):406. https:\/\/doi.org\/10.1093\/rheumatology\/kep392","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6678_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/ard.2008.099382","volume":"68","author":"JS Smolen","year":"2009","unstructured":"Smolen JS, Aletaha D, Steiner G (2009) Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis 68(2):159\u2013162. https:\/\/doi.org\/10.1136\/ard.2008.099382","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6678_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","volume":"73","author":"JA van Nies","year":"2014","unstructured":"van Nies JA, Krabben A, Schoones JW, Huizinga TWJ, Kloppenburg M, van der Helm-van Mil AHM (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861\u2013870. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203130","journal-title":"Ann Rheum Dis"},{"key":"6678_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-018-1667-z","volume":"20","author":"TA Stamm","year":"2018","unstructured":"Stamm TA, Machold KP, Aletaha D, Alasti F, Lipsky P, Pisetsky D et al (2018) Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial. Arthritis Res Ther 20:174. https:\/\/doi.org\/10.1186\/s13075-018-1667-z","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"6678_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA van Gaalen","year":"2004","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes REM, Huizinga TWJ (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3):709\u2013715. https:\/\/doi.org\/10.1002\/art.20044","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6678_CR18","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1002\/art.11269","volume":"48","author":"MA Quinn","year":"2003","unstructured":"Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 48(11):3039\u20133045. https:\/\/doi.org\/10.1002\/art.11269","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6678_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3899\/jrheum.160693","volume":"44","author":"GH Brinkmann","year":"2017","unstructured":"Brinkmann GH, Norli ES, Kvien TK, Haugen AJ, Gr\u00f8vle LJ, Nygaard H et al (2017) Disease characteristics and rheumatoid arthritis development in patients with early undifferentiated arthritis: A 2-year followup study. J Rheumatol 44(2):154\u2013161. https:\/\/doi.org\/10.3899\/jrheum.160693","journal-title":"J Rheumatol"},{"key":"6678_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00296-019-04248-1","volume":"39","author":"D Prasanna Misra","year":"2019","unstructured":"Prasanna Misra D, Agarwal V (2019) Real-world evidence in rheumatic diseases: relevance and lessons learnt. Rheumatol Int 39:403\u2013416. https:\/\/doi.org\/10.1007\/s00296-019-04248-1","journal-title":"Rheumatol Int"},{"issue":"1","key":"6678_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.reuma.2014.05.006","volume":"11","author":"S Rodr\u00edguez-Muguruza","year":"2015","unstructured":"Rodr\u00edguez-Muguruza S, Mart\u00ednez-Morillo M, Riveros-Frutos A, Tena X (2015) What is the outcome of undifferentiated arthritis? Reumatol Clin 11(1):57\u201358. https:\/\/doi.org\/10.1016\/j.reuma.2014.05.006","journal-title":"Reumatol Clin"},{"issue":"8","key":"6678_CR22","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/rheumatology\/keac127","volume":"61","author":"S Pazmino","year":"2022","unstructured":"Pazmino S, Westhovens R, Doumen M, Bertrand D, Verschueren P (2022) Undifferentiated arthritis, not just another early manifestation of rheumatoid arthritis. Rheumatology (Oxford) 61(8):3101\u20133103. https:\/\/doi.org\/10.1093\/rheumatology\/keac127","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"6678_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/annrheumdis-2021-220403","volume":"80","author":"JM Maassen","year":"2021","unstructured":"Maassen JM, Sobr\u00edn RDS, Bergstra SA, Goekoop R, Huizinga TWJ, Allaart CF (2021) Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies. Ann Rheum Dis 80(9):1124\u20131129. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220403","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6678_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/art.10727","volume":"48","author":"MAS Bukhari","year":"2003","unstructured":"Bukhari MAS, Wiles NJ, Lunt M, Harrison BJ, Scott DGI, Symmons DPM, Silman AJ (2003) Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years. Arthritis Rheum 48(1):46\u201353. https:\/\/doi.org\/10.1002\/art.10727","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6678_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/annrheumdis-2013-203243","volume":"73","author":"L Heimans","year":"2014","unstructured":"Heimans L, Wevers-de Boer KVC, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C et al (2014) A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Ann Rheum Dis 73(7):1356\u20131361. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203243","journal-title":"Ann Rheum Dis"},{"key":"6678_CR26","doi-asserted-by":"publisher","unstructured":"Wiles NJ, Lunt M, Barrett EM, Bukhari M, Silman AJ, Symmons DPM, Dunn G. (200) Reduced disability at five years with early treatment of inflammatory polyarthritis. Arthritis Rheum 44(5):1033\u201342. https:\/\/doi.org\/10.1002\/1529-0131(200105)44:5<1033::AID-ANR182>3.0.CO;2-G","DOI":"10.1002\/1529-0131(200105)44:5<1033::AID-ANR182>3.0.CO;2-G"},{"issue":"11","key":"6678_CR27","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1007\/s10067-021-05831-3","volume":"40","author":"S Ebrahimian","year":"2021","unstructured":"Ebrahimian S, Salami A, Malek Mahdavi A, Esalatmanesh K, Khabbazi A, Hajialilo M (2021) Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study Clin Rheumatol 40(11):4485\u20134491. https:\/\/doi.org\/10.1007\/s10067-021-05831-3","journal-title":"A cohort study Clin Rheumatol"},{"issue":"8","key":"6678_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/rheumatology\/keu477","volume":"54","author":"KVC Wevers-de Boer","year":"2015","unstructured":"Wevers-de Boer KVC, Heimans L, Visser K, Schouffoer AA, Molenaar ETH, van Groenendael JH et al (2015) Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment. Rheumatology (Oxford) 54(8):1380\u20131384. https:\/\/doi.org\/10.1093\/rheumatology\/keu477","journal-title":"Rheumatology (Oxford)"},{"key":"6678_CR29","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1136\/annrheumdis-2011-200736","volume":"71","author":"K Wevers-de Boer","year":"2012","unstructured":"Wevers-de Boer K, Visser K, Heimans L, Karel Ronday H, Molenaar E, Groenendael JHLM et al (2012) Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Ann Rheum Dis 71:14727. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200736","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6678_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA van Gaalen","year":"2004","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL et al (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3):709\u2013715. https:\/\/doi.org\/10.1002\/art.20044","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6678_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","volume":"13","author":"NA Patsopoulos","year":"2011","unstructured":"Patsopoulos NA (2011) A pragmatic view on pragmatic trials. Review Dialogues Clin Neurosci 13(2):217\u2013224. https:\/\/doi.org\/10.31887\/DCNS.2011.13.2\/npatsopoulos","journal-title":"Review Dialogues Clin Neurosci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06678-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:12:08Z","timestamp":1697710328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06678-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6678"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06678-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in compliance with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}